Claude Nicaise - Director at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SRPT on Nasdaq
All Insider Reports
All Insider Reports

Claude Nicaise - trading volume in the past year for Sarepta Therapeutics, Inc.

Holdings reported by Claude Nicaise for Sarepta Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 31,532 $669,424 $21.23 29 Jan 2026 Direct
Stock Option (right to buy) 0 29 Jan 2026 Direct Common Stock
Stock Options (right to buy) 0 12 Mar 2025 Direct Common Stock

Transactions reported by Claude Nicaise for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.